Michael Summerhill

Michael J. Summerhill is a partner in the firm’s Litigation practice group. He is a seasoned litigator with extensive appellate and trial court level experience. He represents clients ranging from Fortune 500 companies to startups in a variety of industries, including health care, software, health information technology, financial services and FinTech, medical device, consumer products, and venture capital. Mike also arbitrates commercial disputes before the American Arbitration Association and other alternative dispute resolution forums. My focus I have more than 20 years of experience litigating cases in federal and state courts. My services range from complex commercial disputes involving a variety of industries, to appellate work, to significant experience in the health tech, FinTech and GreenTech industries. Complex Commercial DisputesI represent clients in a variety of substantive areas including complex mass torts, securities fraud, shareholder derivative claims, fraudulent transfer claims, and complex commercial claims. AppellateI argue appellate matters and draft briefs for various appeals, in all appellate courts, including the U.S. and state Supreme Courts. Fraudulent Transfer LitigationI have significant experience litigating fraudulent transfer claims, particularly those brought by court-appointed receivers/trustees. Looking ahead Artificial intelligence will continue to improve, particularly in the health care space. With technological improvement comes new and emerging litigation risks, and I have been closely following developments and best practices toward helping clients manage these risks. Economic disruptions following COVID-19 and geo-political developments will continue to impact businesses. All disruptions, however, present opportunities, particularly for an innovation-based economy. We constantly monitor emerging technologies with an eye toward predicting risk as well as capital flows. Consolidation in all industries continues to be a major contributor of company expansion as well as litigation risk, whether from shareholders, regulators or from unforeseen risks from acquired assets.